MDWD: MediWound Ltd.
2022-07-11 07:00:00
MediWound Announces Positive Initial Data from its U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
MDWD: MediWound Ltd.
2022-07-07 07:00:00
MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers
MDWD: MediWound Ltd.
2022-05-12 07:00:00
MediWound Announces Positive Results from Its U.S. Phase 2 Trial of EscharEx for Debridement of Chronic Wounds
Pupm&Dump trading strategy idea.
$MDWD is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $5,52;
stop-loss — $5,97;
take-profit — $4,62.
Do not view this idea as a recommendation for trading or investing. It is...
What I see...
+ Inside Hammer, NR7, and NR3 combo!!
+ ... with 10ma support
+ High vol.
+ MACD is flat but bullish
+ RSI at 56
+ Bollinger is narrow
+ Low price stock
- 1st Resistance at 2.18; 2nd at 2.40
- 10ma is not piercing through the body
- Very low vol. stock
What I setup...
+ Long entry above -2d
- Stop at today's low
+ Target at 2.4
:: Duration - 5 to...
Company Information
MediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company's product, NexoBrid, is indicated for the removal of dead or damaged...
You can see that MDWD has moved up on higher volume recently from what appears to be the end of its down trend, and it is now in a clear pennant/ascending triangle. I did a search for "analyst opinion" on MediWound and it seems that the consensus is that it's a "strong buy". I don't understand why those experts say such things when the company is losing money,...
